Divis Laboratories Ltd (DIVISLAB) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Divis Laboratories Ltd on NSE and BSE, with an AI summary of each filing.
Intimation of schedule of Q2FY2027 earnings call to be held on November 07, 2026 at 14:00 Hrs (IST).
Intimation · 07 Nov 2026, 2:00 pm
Divi’s Laboratories Schedules Q2FY27 Earnings Conference Call Divi’s Laboratories Limited will announce its unaudited financial results for the quarter and half-year ended 30th Sep'26 on 7th Nov'26. Following the results declaration, company management will host an earnings conference call on 7th Nov'26 at 14:00 hrs IST to discuss financial performance. Pre-registration via DiamondPass is available alongside universal dial-in access (+91 22 6280 1526 / +91 22 7115 8341), with call transcripts to be published on the company's official website.
To consider and approve the financial results for the period ended September 30, 2026
Intimation · 07 Nov 2026, 5:30 am
Divi's Laboratories Limited has informed the Exchange about Board Meeting to be held on 07-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 .
Intimation · 07 Nov 2026, 5:30 am
Divis Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2026 ,inter alia, to consider and approve unaudited financial results ....
Intimation · 07 Nov 2026, 5:30 am
Divi's Laboratories Schedules Board Meeting for Q2FY27 Results on 7th Nov'26 Divi's Laboratories Limited announced that its Board of Directors will meet on 7th Nov'26 to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26. In accordance with insider trading regulations, the trading window for dealing in company securities has been closed since 1st Oct'26 and will remain shut until 9th Nov'26, concluding 48 hours post-results declaration.
Submission of Scrutinizer''s report on 36th AGM resolutions.
Annual General Meeting · 11 Aug 2026, 12:58 am
Outcome of 36th AGM - submission of AGM proceedings, voting results and Scrutinizer''s report.
Annual General Meeting · 11 Aug 2026, 12:55 am
Submission of transcript of Earnings Conference Call held on August 01, 2026
Transcript · 06 Aug 2026, 7:56 pm
Intimation of Q1FY27 earnings call audio recording.
Audio / Video · 01 Aug 2026, 9:22 pm
Divi's Labs makes Q1 FY27 earnings call audio available Divi's Laboratories has uploaded the audio recording of its earnings conference call for Q1 FY27, the quarter ended Jun 30, '26. The call was held on Aug 01, '26. This disclosure complies with Regulation 30 of SEBI's Listing Obligations and Disclosure Requirements, Regulations, 2015. The recording is accessible on the company's website under the investor relations section.
As per enclosed letter.
Change in Management · 01 Aug 2026, 5:08 pm
Divi's Labs Q1FY27: Strong YoY Growth in Revenue and Profitability Divi's Laboratories reported strong consolidated results for the quarter ending 30 Jun'26. Total income grew 24.3% YoY to ₹3,144 crores, while Profit After Tax (PAT) surged 65.5% YoY to ₹902 crores. Sequentially, PAT increased by 20.1% QoQ. On a standalone basis, revenue was ₹3,037 crores and PAT stood at ₹891 crores, up 60% YoY. The company also announced the appointment of two Senior Management Personnel, Mr. B. Vara Prasad and Mr. J. Srinivasa Rao, effective 01 Aug'26.
Outcome of Board meeting held on August 01, 2026.
Outcome · 01 Aug 2026, 5:05 pm
Divis Laboratories Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Crore) ■ Revenue: 3,080 (+27.8% YoY | +8.8% QoQ) ■ EBITDA: 1,255 (+72.2% YoY | +34.4% QoQ) ■ EBITDA Margin (%): 40.7 (+1050 bps YoY | +775 bps QoQ) ■ PAT: 902 (+65.5% YoY | +20.1% QoQ) ■ EPS (INR): 34.0 (+65.7% YoY | +19.9% QoQ)
Intimation of retirement of Senior Management Personnel as detailed in the enclosed letter.
Change in Management · 31 Jul 2026, 2:43 pm
Divi's Labs Announces Retirement of Two Senior Executives Divi's Laboratories announced the retirement of two senior management personnel effective 31st Jul'26. Mr. L. Ramesh Babu, Vice President (Procurement), and Mr. D. Madhu Babu, Vice President (Projects), will cease to be Senior Management Personnel upon their retirement. The company confirmed the cessations are due to retirement. The departures involve key operational roles, potentially impacting procurement strategy and project execution leadership. Further details on succession planning were not provided in the filing.
Schedule of earnings conference call for Q1 FY27
Intimation · 01 Aug 2026, 2:00 pm
Divi's Labs Schedules Q1 FY27 Earnings Conference Call for Aug 01, 2026 Divi's Laboratories will release its unaudited financial results for Q1 FY27, the quarter ended Jun 30, 2026, on Aug 01, 2026. The company's management will host an earnings conference call on the same day at 14:00 hrs IST to discuss financial performance. A transcript of the call will be made available on the company's website.
Divis Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2026 ,inter alia, to consider and approve the unaudited financial ....
Intimation · 01 Aug 2026, 5:30 am
Divi's Laboratories Board Meeting Scheduled to Approve Q1FY27 Results Divi's Laboratories has scheduled a Board of Directors meeting for Sat, Aug 01, '26. The agenda includes the consideration and approval of unaudited standalone and consolidated financial results for the quarter ended Jun 30, '26. In connection with this, the trading window for company securities has been closed from Jul 01, '26 and will remain closed until Aug 03, '26, which is 48 hours after the results are declared. This is a key event for tracking the company's Q1FY27 performance.
Intimation of notice of 36th AGM to be held on August 10, 2026.
Annual General Meeting · 15 Jul 2026, 11:14 pm
Submission of BRSR report for the FY 2025-26.
Others (Uncategorized) · 15 Jul 2026, 11:11 pm
Divi's Laboratories Submits FY26 Business Responsibility and Sustainability Report Divi's Laboratories filed its Business Responsibility and Sustainability Report for FY26 on 15 Jul'26, detailing key ESG metrics. Exports contributed 89% to turnover. For FY26, the company reported Scope 1 GHG emissions of 371,697 tCO₂e and Scope 2 emissions of 378,516 tCO₂e. Total energy consumption stood at 54.97 million GJ. The permanent employee turnover rate was 10.21%. Shareholder complaints rose to 102 from 79 in FY25, while customer complaints decreased to 35 from 49. Accounts payable days increased to 94 from 84 YoY.
Notice of 36th Annual General Meeting and Annual Report for the financial year 2025-26.
Others (Uncategorized) · 15 Jul 2026, 8:18 pm
As per enclosed letter.
Dividend · 11 Jun 2026, 2:38 pm
Divi's Laboratories Recommends ₹30 Per Share Dividend for FY26 Divi's Laboratories' Board has recommended a dividend of ₹30 per share (1,500%) for FY ended 31 Mar'26, subject to shareholder approval at the AGM on 10 Aug'26. The record date is set for 24 Jul'26, with the dividend to be distributed on or after 14 Aug'26. The company also detailed the process for income tax deduction at source, specifying TDS rates for resident (10-20%) and non-resident (20% plus cess) shareholders, and outlined procedures for claiming exemptions or lower rates before the 24 Jul'26 cutoff.
Submission of transcript of Earnings Conference Call held on May 23, 2026
Transcript · 29 May 2026, 4:01 pm
As per enclosed letter.
Financial Result · 25 May 2026, 2:26 pm
Divis Laboratories Ltd - Financial Result for the Quarter ended 31st Mar'26 (Consolidated, INR Crore) ■ Revenue: 2,831 (+9.5% YoY | +8.7% QoQ) ■ EBITDA: 934 (+5.4% YoY | +4.9% QoQ) ■ EBITDA Margin (%): 33.0 (-128 bps YoY | -119 bps QoQ) ■ PAT: 751 (+13.4% YoY | +28.8% QoQ) ■ EPS (INR): 28.3 (+13.6% YoY | +28.8% QoQ)
Audio recording of Q4 FY26 earnings conference call held on May 23, 2026.
Audio / Video · 23 May 2026, 11:58 pm
Divi's Laboratories Makes Q4 FY26 Earnings Call Audio Available Divi's Laboratories has uploaded the audio recording of its earnings conference call for the quarter and year ended Mar 31, 2026. The call was held on May 23, 2026, at 14:30 IST. The recording is now accessible on the company's website under the Investors relations section, as per SEBI's listing regulations. This provides investors with direct access to management's discussion and analysis of the company's financial performance and outlook.
The Board of Directors at its meeting held on May 23, 2026 have recommended a dividend of Rs. 30/- per share (i.e. @1500%), subject to approval at the ensuing Annual General Meeting.
Dividend · 23 May 2026, 6:26 pm
Divi's Labs Q4FY26 PAT Rises 13% YoY, Board Recommends ₹30 Dividend Divi's Laboratories reported consolidated Q4FY26 results with revenue at ₹2,831 crore (up 9.5% YoY) and PAT at ₹751 crore (up 13.4% YoY). For FY26, consolidated revenue grew 14% YoY to ₹11,067 crore, while PAT increased 17.2% to ₹2,568 crore. The Board recommended a final dividend of ₹30 per share (1500%) for FY26. The record date for the dividend payment is set for 24 Jul'26. FY26 PBT includes a one-time exceptional expense of ₹74 crore related to the impact of new labour codes.
As per enclosed intimation letter.
Dividend · 23 May 2026, 5:50 pm
Divi's Labs Q4FY26 PAT Jumps 13% YoY, Board Declares ₹30 Dividend Divi's Laboratories reported Q4FY26 consolidated PAT of ₹751 crore, up 13.4% YoY, on revenue of ₹2,986 crore (+11.8% YoY). For FY26, consolidated PAT grew 17.2% YoY to ₹2,568 crore, while revenue increased 14.0% YoY to ₹11,067 crore. The Board recommended a final dividend of ₹30 per share (1,500%) for FY26. The record date for the dividend payment is set for 24 Jul'26, and the AGM will be held on 10 Aug'26. Audit reports were issued with an unmodified opinion.
Outcome of Board meeting held on May 23, 2026.
Outcome · 23 May 2026, 5:42 pm
Divis Laboratories Ltd - Financial Result for the Quarter ended 31st Mar'26 (Consolidated, INR Crore) ■ Revenue: 2,831 (+9.5% YoY | +8.7% QoQ) ■ EBITDA: 934 (+5.4% YoY | +4.9% QoQ) ■ EBITDA Margin (%): 33.0 (-128 bps YoY | -119 bps QoQ) ■ PAT: 751 (+13.4% YoY | +28.8% QoQ) ■ EPS (INR): 28.3 (+13.6% YoY | +28.8% QoQ)
Intimation of schedule of earnings conference call for the quarter and year ended March 31, 2026 to be held on May 23, 2026 at 14:30 Hrs (IST).
Intimation · 23 May 2026, 2:30 pm
Divi's Laboratories Schedules Q4FY26 Earnings Call for May 23, 2026 Divi's Laboratories (DIVISLAB) will release its audited financial results for the quarter and year ended 31st Mar'26 on 23rd May'26. Company management will host an earnings conference call to discuss the financial performance on the same day at 14:30 hrs IST. A transcript of the call will be made available on the company's website post-event.
Divis Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2026 ,inter alia, to consider and approve audited standalone and consolidated ....
Intimation · 23 May 2026, 5:30 am
Divi's Laboratories Board Meeting Scheduled for Q4FY26 Results and Dividend Divi's Laboratories has scheduled a Board of Directors meeting on Sat, 23rd May'26 to consider and approve the audited standalone and consolidated financial results for the quarter and year ended Mar 31, 2026. The board will also consider a dividend recommendation for the financial year 2025-26. The trading window for dealing in company securities is closed from Apr 01, 2026, and will reopen on May 26, 2026, 48 hours after the results are declared.